tradingkey.logo

RenovoRx Inc <RNXT.OQ> expected to post a loss of 8 cents a share - Earnings Preview

ReutersMay 13, 2025 8:28 PM
  • RenovoRx Inc RNXT.OQ RNXT.O is expected to show a rise in quarterly revenue when it reports results on May 15 for the period ending March 31 2025

  • The Mountain View California-based company is expected to report revenue of $225 thousand, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for RenovoRx Inc is for a loss of 8 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 6.5% in the last three months. ​

  • Wall Street's median 12-month price target for RenovoRx Inc is $4.00​, above​ its last closing price of $1.06. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.12

-0.11

-0.13

Missed

-18.2

Sep. 30 2024

-0.12

-0.12

-0.10

Beat

16.7

Jun. 30 2024

-0.10

-0.10

-0.10

Met

0​

Mar. 31 2024

-0.13

-0.14

-0.07

Beat

51.7

​​Dec. 31 2023

-0.30

-0.30

-0.31

Missed

-2.2

Sep. 30 2023

-0.30

-0.30

-0.13

Beat

56.7​

Jun. 30 2023

-0.25

-0.25

-0.31

Missed

-24

Mar. 31 2023

-0.25

-0.25

-0.36

Missed

-44

This summary was machine generated May 13 at 20:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles